Do NGS-based techniques represent a first-line testing in suspected Duchenne muscular dystrophy?

Clin Case Rep. 2022 Jun 2;10(6):e05916. doi: 10.1002/ccr3.5916. eCollection 2022 Jun.

Abstract

Duchenne muscular dystrophy (DMD) is caused by mutations in the dystrophin gene, which mostly affects boys. The subject was an 8-year-old child who had typical symptoms of muscle weakness. The NGS may be used as an efficient and cost-effective molecular diagnostic strategy for identifying patients with DMD.

Keywords: Duchenne Muscular Dystrophy; genetic diagnosis; molecular diagnosis; next‐generation sequencing.

Publication types

  • Case Reports